Alphatec Holdings, Inc. (NASDAQ:ATEC) was the recipient of a large decrease in short interest in June. As of June 30th, there was short interest totalling 679,792 shares, a decrease of 44.1% from the June 15th total of 1,216,845 shares. Based on an average daily trading volume, of 15,713 shares, the short-interest ratio is presently 43.3 days. Currently, 11.0% of the company’s shares are sold short.

Several large investors have recently modified their holdings of the company. Numeric Investors LLC raised its stake in shares of Alphatec Holdings by 28.9% in the fourth quarter. Numeric Investors LLC now owns 92,082 shares of the medical technology company’s stock worth $296,000 after buying an additional 20,628 shares in the last quarter. Renaissance Technologies LLC raised its stake in shares of Alphatec Holdings by 85.3% in the fourth quarter. Renaissance Technologies LLC now owns 313,545 shares of the medical technology company’s stock worth $1,006,000 after buying an additional 144,300 shares in the last quarter. Finally, Broadfin Capital LLC acquired a new stake in shares of Alphatec Holdings during the first quarter worth $527,000. Hedge funds and other institutional investors own 20.83% of the company’s stock.

Alphatec Holdings (ATEC) opened at 1.69 on Monday. The firm’s 50 day moving average price is $1.97 and its 200-day moving average price is $2.73. Alphatec Holdings has a 12-month low of $1.60 and a 12-month high of $9.65.

TRADEMARK VIOLATION WARNING: This piece of content was originally reported by American Banking News and is the property of of American Banking News. If you are reading this piece of content on another website, it was copied illegally and republished in violation of United States and international copyright & trademark law. The original version of this piece of content can be read at https://www.americanbankingnews.com/2017/07/17/short-interest-in-alphatec-holdings-inc-atec-decreases-by-44-1.html.

Alphatec Holdings Company Profile

Alphatec Holdings, Inc is a medical technology company. The Company through its subsidiary, Alphatec Spine, Inc and its subsidiaries, designs, develops, manufactures and markets products for the surgical treatment of spine disorders. Its product portfolio and pipeline addresses the cervical, thoracolumbar and intervertebral regions of the spine and covers a range of spinal disorders and surgical procedures.

Receive News & Ratings for Alphatec Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alphatec Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.